Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
WTX-212 by West Lake Biomedical Technology (Hangzhou) for Cervical Cancer: Likelihood of Approval
WTX-212 is under clinical development by West Lake Biomedical Technology (Hangzhou) and currently in Phase I for Cervical Cancer. According...
Data Insights
WTX-212 by West Lake Biomedical Technology (Hangzhou) for Esophageal Cancer: Likelihood of Approval
WTX-212 is under clinical development by West Lake Biomedical Technology (Hangzhou) and currently in Phase I for Esophageal Cancer. According...